{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T02:02:19Z","timestamp":1784599339830,"version":"3.55.0"},"reference-count":27,"publisher":"ARAN Ediciones","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hipertensi\u00f3n y Riesgo Vascular"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.hipert.2020.06.003","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T06:57:05Z","timestamp":1592463425000},"page":"176-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["COVID-19, hipertensi\u00f3n y enfermedad cardiovascular"],"prefix":"10.20960","volume":"37","author":[{"given":"M.","family":"Salazar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Barochiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Espeche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Ennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8588","reference":[{"key":"10.1016\/j.hipert.2020.06.003_bib0140","doi-asserted-by":"crossref","first-page":"1239-1242","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA."},{"key":"10.1016\/j.hipert.2020.06.003_bib0145","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41591-020-0822-7","article-title":"Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China","volume":"26","author":"Wu","year":"2020","journal-title":"Nat Med."},{"key":"10.1016\/j.hipert.2020.06.003_bib0150","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","author":"Guan","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.hipert.2020.06.003_bib0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","article-title":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: A systematic review and meta-analysis","volume":"94","author":"Yang","year":"2020","journal-title":"Int J Infect Dis."},{"key":"10.1016\/j.hipert.2020.06.003_bib0160","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4683","article-title":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy","author":"Onder","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.hipert.2020.06.003_bib0165","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.5394","article-title":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy","author":"Grasselli","year":"2020","journal-title":"JAMA."},{"key":"10.1016\/j.hipert.2020.06.003_bib0170","doi-asserted-by":"crossref","first-page":"382","DOI":"10.15585\/mmwr.mm6913e2","article-title":"Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 \u2014 United States, February 12-March 28, 2020","volume":"69","author":"Chow","year":"2020","journal-title":"Morb Mortal Wkly Rep."},{"key":"10.1016\/j.hipert.2020.06.003_bib0175","unstructured":"CDC. National Health Statistics [consultado 2020 Jun 9]. Disponible en: https:\/\/www.cdc.gov\/media\/dpk\/diseases-and-conditions\/coronavirus\/coronavirus-2020.html"},{"key":"10.1016\/j.hipert.2020.06.003_bib0180","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa415","article-title":"Obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission","author":"Lighter","year":"2020","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.hipert.2020.06.003_bib0185","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.hipert.2020.06.003_bib0190","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","author":"Shi","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.hipert.2020.06.003_bib0195","first-page":"1858","article-title":"COVID-19-related myocarditis in a 21-year-old female patient","volume":"41","author":"Kim","year":"2020","journal-title":"Eur Heart J."},{"key":"10.1016\/j.hipert.2020.06.003_bib0200","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/eurheartj\/ehaa306","article-title":"Typical takotsubo syndrome triggered by SARS-CoV-2 infection","volume":"41","author":"Meyer","year":"2020","journal-title":"Eur Heart J."},{"key":"10.1016\/j.hipert.2020.06.003_bib0205","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1093\/eurheartj\/ehaa307","article-title":"Transient complete heart block in a patient with critical COVID-19","volume":"41","author":"Azarkish","year":"2020","journal-title":"Eur Heart J."},{"key":"10.1016\/j.hipert.2020.06.003_bib0210","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1161\/CIRCULATIONAHA.120.046941","article-title":"COVID-19 and cardiovascular disease","volume":"141","author":"Clerkin","year":"2020","journal-title":"Circulation."},{"key":"10.1016\/j.hipert.2020.06.003_bib0215","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/eurheartj\/ehaa235","article-title":"SARS-CoV2: Should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?","volume":"41","author":"Kuster","year":"2020","journal-title":"Eur Heart J."},{"key":"10.1016\/j.hipert.2020.06.003_bib0220","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/j.jacc.2020.03.031","article-title":"Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic","volume":"75","author":"Driggin","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.hipert.2020.06.003_bib0225","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1282","article-title":"Coronavirus disease 2019 (COVID-19) infection and renin angiotensin system blockers","author":"Bavishi","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.hipert.2020.06.003_bib0230","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/HYPERTENSIONAHA.120.15082","article-title":"Renin-angiotensin system blockers and the COVID-19 pandemic: At present there is no evidence to abandon renin-angiotensin system blockers","volume":"75","author":"Danser","year":"2020","journal-title":"Hypertension."},{"key":"10.1016\/j.hipert.2020.06.003_bib0235","doi-asserted-by":"crossref","first-page":"m1313","DOI":"10.1136\/bmj.m1313","article-title":"Drugs and the renin-angiotensin system in COVID-19","volume":"369","author":"Aronson","year":"2020","journal-title":"BMJ."},{"key":"10.1016\/j.hipert.2020.06.003_bib0240","doi-asserted-by":"crossref","first-page":"e016509","DOI":"10.1161\/JAHA.120.016509","article-title":"Coronavirus disease 2019 (COVID-19): Do angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers have a biphasic effect?","volume":"9","author":"Sommerstein","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.hipert.2020.06.003_bib0245","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell."},{"key":"10.1016\/j.hipert.2020.06.003_bib0250","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1329","article-title":"The dilemma of coronavirus disease 2019, aging, and cardiovascular disease: Insights from cardiovascular aging science","author":"AlGhatrif","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.hipert.2020.06.003_bib0255","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation."},{"key":"10.1016\/j.hipert.2020.06.003_bib0260","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","article-title":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension","volume":"9","author":"Meng","year":"2020","journal-title":"Emerg Microbes Infect."},{"key":"10.1016\/j.hipert.2020.06.003_bib0265","article-title":"Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries","author":"Kotseva","year":"2020","journal-title":"Eur J Prev Cardiol."},{"key":"10.1016\/j.hipert.2020.06.003_bib0270","doi-asserted-by":"crossref","first-page":"e0183953","DOI":"10.1371\/journal.pone.0183953","article-title":"Prevalence, awareness, treatment and control of diabetes and impaired fasting glucose in the Southern Cone of Latin America","volume":"12","author":"Irazola","year":"2017","journal-title":"PLoS One."}],"container-title":["Hipertensi\u00f3n y Riesgo Vascular"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1889183720300659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1889183720300659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T01:15:16Z","timestamp":1784596516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1889183720300659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1889183720300659"],"URL":"https:\/\/doi.org\/10.1016\/j.hipert.2020.06.003","relation":{},"ISSN":["1889-1837"],"issn-type":[{"value":"1889-1837","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19, hipertensi\u00f3n y enfermedad cardiovascular","name":"articletitle","label":"Article Title"},{"value":"Hipertensi\u00f3n y Riesgo Vascular","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hipert.2020.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 SEH-LELHA. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}